Related Experiment Videos
Immunologic abnormalities associated with acute ischemic heart disease (a pilot study).
1Mount Zion Hospital and Medical Center, San Francisco, California.
Annals of Allergy
|October 1, 1989
Summary
Patients with myocardial infarction (MI) show reduced T lymphocytes, a key immune cell. Lower T-cell counts in MI patients correlate with higher mortality, suggesting a potential prognostic marker for early intervention.
Area of Science:
- Immunology
- Cardiology
- Cellular Biology
Background:
- Patients with myocardial infarction (MI) often exhibit altered immune responses.
- Cutaneous cellular immunity and T lymphocyte populations are critical components of the immune system.
Purpose of the Study:
- To compare immune cell profiles in patients with MI versus healthy controls and other cardiovascular disease patients.
- To investigate the correlation between T lymphocyte levels and survival rates in MI patients.
Main Methods:
- In vivo and in vitro studies were conducted.
- Comparison of T lymphocyte counts and cutaneous cellular immunity between MI patients and control groups.
- Development of a new method for categorizing in vitro T-cells.
Main Results:
- MI patients demonstrated significantly diminished cutaneous cellular immunity and T lymphocyte numbers compared to controls.
- A significant difference in survival was observed between control patients and those who did not survive MI within 4 weeks (P < .001).
- Patients who died within one month had 3.6 times fewer circulating T-cells than age-matched controls.
Conclusions:
- Reduced T lymphocyte counts post-MI may serve as an indicator of poor prognosis.
- Identifying patients with low T-cell numbers could prompt early medical intervention to improve recovery outcomes.
- This study highlights the prognostic value of T-cell monitoring in myocardial infarction patients.